ZADEC ApS: Financial statements 2023
CVR: 29312206
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ZADEC ApS (CVR 29312206) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -150,400 and a net result of DKK -354,620 compared with DKK -248,825 the year before. Equity in the 2023 report amounted to DKK -2,022,338.
- Gross Profit
- DKK -150,400
- Profit/Loss
- DKK -354,620
- Equity
- DKK -2,022,338
- Total Assets
- DKK 433,751
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -150 t. | -355 t. | -2 mio. | - |
| 2022 | - | -205 t. | -249 t. | -1.7 mio. | - |
| 2021 | - | -224 t. | -273 t. | -1.4 mio. | - |
| 2020 | - | -231 t. | -356 t. | -1.1 mio. | - |
| 2019 | - | -235 t. | -222 t. | -790 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ZADEC ApS has published its annual report for 2022. Gross profit came to DKK -204,520, and the net result was DKK -248,825.
About ZADEC ApS
ZADEC ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S and FEY HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -115,999 and a net result of DKK -377,192 compared with DKK -308,786 the year before. Equity in the 2025 report amounted to DKK -2,708,317.